Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

AstraZeneca pledges 9m more Covid vaccine jabs to EU

Mon, 01st Feb 2021 07:34

(Sharecast News) - AstraZeneca is set to supply an extra nine million doses of its Covid-19 vaccine to the European Union after a high-profile row over shortages.
European Commission President Ursula Von der Leyen said the extra doses will come in the first three months of the year, making a total of 40m for that period.

Von der Leyen said the company, which has production sites in the UK and on the Continent, will start deliveries one week earlier than planned and expand its manufacturing capacity in Europe.

The Anglo-Swiss pharmaceutical giant recently told Brussels the initial number of doses it could supply to the bloc would be lower than first thought, due to manufacturing issues, which sparked a dispute over supplies.

The pace of the vaccine rollout in the 27-member bloc has so far been slow and Von der Leyen admitted the situation would be "difficult" in March and April - but wanted 70% of adults in Europe to have a jab by the end of the summer.

Last week, AstraZeneca said it could bring forward some deliveries to the EU and offered eight million more jabs to the bloc in an attempt to defuse the row.

But an EU official said that was far short of what was originally promised as AstraZeneca had committed to at least 80 million shots in the first quarter of the year.

Related Shares

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.